Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir-Reference-Cited by-同舟云学术

Updated clinical risk factor analysis of suspected hypersensitivity reactions to abacavir

Published:2004-10-26 Issue:12 Volume:38 Page:2171-2172
ISSN:1060-0280
Container-title:Annals of Pharmacotherapy
language:en
Short-container-title:Ann Pharmacother

Author:

Cutrell Amy G¹,Hernandez Jaime E²,Fleming Julie W³,Edwards Mark T⁴,Moore Martha Anne⁵,Brothers Cindy H⁶,Scott Trevor R⁷

Affiliation:

1. Associate Director, Statistics and Programming, GlaxoSmithKline, Research Triangle Park, North Carolina

2. Senior Director & Medical Monitor, Infectious Diseases Medicine Development Center—HIV, GlaxoSmithKline, Five Moore Drive, Research Triangle Park, North Carolina 27709-3398, fax 919/315-6029,

3. Lead Clinical Development Scientist, GlaxoSmithKline

4. Statistician, Tomorrow Associates, Inc., Cary, North Carolina

5. Director, Regulatory Affairs, GlaxoSmithKline

6. Associate Director, GlaxoSmithKline

7. Group Director, Infectious Diseases Medicine Development Center—HIV, GlaxoSmithKline

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Link

http://journals.sagepub.com/doi/pdf/10.1345/aph.1E202

Reference3 articles.

1. Hypersensitivity reactions during therapy with the nucleoside reverse transcriptase inhibitor abacavir

2. Risk factor analysis of hypersensitivity reactions to abacavir

3. Genetic variations in HLA-B region and hypersensitivity reactions to abacavir

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severe abacavir hypersensitivity reaction in a patient with human immunodeficiency virus infection: a case report;Journal of Medical Case Reports;2022-11-08

2. Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors;Communications Biology;2022-02-16

3. Pharmacokinetics, Safety, and Tolerability of a Single Oral Dose of Abacavir/Dolutegravir/Lamivudine Combination Tablets in Healthy Japanese Study Participants;Clinical Pharmacology in Drug Development;2021-07-15

4. Drug Reaction with Eosinophilia and Systemic Symptoms: A Complex Interplay between Drug, T Cells, and Herpesviridae;International Journal of Molecular Sciences;2021-01-23

5. Genetic associations with a fever after measles-containing vaccines;Human Vaccines & Immunotherapeutics;2020-12-22